Previous Close | 9.10 |
Open | 9.10 |
Bid | 2.20 |
Ask | 7.00 |
Strike | 85.00 |
Expire Date | 2024-12-20 |
Day's Range | 9.10 - 9.10 |
Contract Range | N/A |
Volume | |
Open Interest | 26 |
On May 29, 2024, Stewart Strong, President of Global Hospital at Haemonetics Corp (NYSE:HAE), sold 8,857 shares of the company.
On May 29, 2024, Michelle Basil, Executive Vice President and General Counsel of Haemonetics Corp (NYSE:HAE), executed a sale of 12,990 shares of the company at a price of $88.08 per share.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.